University of Nottingham has sold its stake in US-based drug discovery technology developer Crown Bioscience International (CrownBio) to diversified manufacturing conglomerate JSR Corporation for £3.6m ($4.8m), Insider Media has reported.

JSR Corporation originally announced its NT$12bn ($400m) acquisition of CrownBio in December 2017, in what marked the corporate’s largest ever life sciences deal.

Founded in 2006, CrownBio offers a range of translational drug discovery and development services in areas such as advanced oncology, inflammatory conditions and cardiovascular or metabolic diseases…